International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

New corporate member

Arcutis new corporate member

IPC is pleased to welcome Arcutis Biotherapeutics, Inc. as a 2022 Bronze Level Corporate Member. Arcutis, based in Westlake Village, CA, is a medical dermatology company founded in 2016 that champions meaningful innovation to solve the most persistent challenges of patients with immune-mediated dermatological diseases and conditions. “We are delighted to welcome Arcutis Biotherapeutics, Inc. to the IPC family, and look forward to partnering with them to improve the care of people with psoriasis worldwide, through education, research and advocacy,” said IPC CEO Christy Langan.

More information about Arcutis can be found at https://www.arcutis.com/.

Categories

Recent Posts

New IPC Guidelines on Generalized Pustular Psoriasis

Commentary: An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis

Introducing our Latest IPC Councilors: Experts in Psoriasis Treatment and Research

Also Read

Generalized Pustular Psoriasis

New IPC Guidelines on Generalized Pustular Psoriasis

Learn about the new global diagnostic criteria for Generalized Pustular Psoriasis as set by the International Psoriasis Council. Discover the essential features, the importance of accurate diagnosis, and the expected global impact on patient care.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.